Leslie Orne, who currently serves as president and chief commercial officer at Trinity, will succeed outgoing CEO David Fitzhenry effective July 1. Leslie Orne, who currently serves as president and chief commercial officer at Trinity, will succeed outgoing CEO David Fitzhenry effective July 1.
bioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for. | May 15, 2023
15.05.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three months ended March .